Search

everythinglearnresearchcommunity

for

Search:↓

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Thyroid receptor β can help develop new drugs to treat hair loss.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Ruxolitinib may help treat hair loss by reducing inflammation, promoting hair growth signals, and protecting hair follicle immunity.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

M50054 may help treat hepatitis and hair loss from chemotherapy.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

The tumor suppressor BRCA2 helps in cell division by bringing key proteins to the area where cells split.

Oral baricitinib is effective and safe for treating alopecia areata.

Filgotinib completely reversed hair loss in a patient with rheumatoid arthritis and alopecia universalis.

Upadacitinib is effective and safe for treating severe Alopecia Areata in adolescents.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.